Results from a clinical trial show a combination of two synthetic antibodies reduces deaths in hospitalized Covid-19 patients with no earlier immune response. . . . → Read More: Antibodies Help Some Hospitalized Covid-19 Patients
|
|||||
|
       
  |
Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotrophic lateral sclerosis, or ALS. . . . → Read More: Biotechs Partner on Crispr Therapies for Neuro Disorders 
A synthetic biology company and genetics research service are providing analytics on population genomic variations they say are more racially and ethnically diverse. . . . → Read More: Diverse Genomic Variation Analytics Panel Created 
A bioengineering team created a practical technique for using DNA as a medium to store and retrieve vast and rapidly growing volumes of data. . . . → Read More: DNA Data Search, Retrieval Medium Designed 
Biochemists created a polymer film derived from soy proteins in a sustainable process that can replace many of today’s single-use plastics. . . . → Read More: Plant-Based Material Designed to Replace Plastics 
Two U.S. government health agencies agreed to purchase some 1.7 million doses of a Covid-19 antiviral drug, once the drug receives clearance from FDA. . . . → Read More: U.S. to Buy Covid-19 Antiviral Drug in $1.2B Deal 
Apple Inc. is adding new data collection, reporting, and sharing features to its iPhone and watch health apps supported by its latest operating system upgrades. . . . → Read More: Apple Expands Health Data, Trends, Sharing 
A genetic analysis identifies a single genetic variation associated with loss of smell and taste, an early symptom in many people with Covid-19 infections. . . . → Read More: Genetic Link Found for Covid-19 Loss of Smell 
The Food and Drug Administration updated its emergency authorization for a dual-antibody Covid-19 therapy to allow for a lower and injectable dose. . . . → Read More: FDA Okays Lower Dose, Injected Covid-19 Antibodies 
Tests with lab mice show one dose of a lower cost Covid-19 vaccine given with a needle-free patch generates strong antibody and cellular immune responses. . . . → Read More: Low Cost Vaccine, Patch Device Produce Immune Responses |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
